Questions about the use of hepatotropic drugs



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

More and more people are striving to take control of their health by independently preventing and treating diseases, including using over-the-counter medications at their own discretion. The implementation of the concept of responsible self-medication opens up opportunities to significantly improve the accessibility and quality of medical care for a significant number of citizens. Pharmaceutical information helps individuals understand the nuances of choosing medications, medical devices, dietary supplements, and other pharmacy products. A pharmaceutical specialist can also provide guidance on the optimal combination of pharmacotherapy and other treatment approaches. In particular, the wide range of hepatotropic drugs, a significant part of which is available without a doctor's prescription, coupled with the lack of evidence-based data on the effectiveness and safety of some of these drugs, and the increasing prevalence of self-medication among the population, further highlights the issue of over-the-counter availability. An analysis of the literature on the evaluation of the effectiveness and safety of hepatotropic drugs reveals an increase in the number of clinical studies conducted on this group of medications, as well as their inclusion in many clinical guidelines for the treatment of liver, gallbladder, and biliary tract diseases. In this regard, there is a need for specific and clear algorithms for pharmaceutical information in the case of over-the-counter dispensing of hepatotropic drugs

Full Text

Restricted Access

About the authors

Alina Aydova

Kazan (Volga region) Federal University

Author for correspondence.
Email: ajdova_92@mail.ru
ORCID iD: 0009-0003-9248-3483
SPIN-code: 4327-2673

без степени, ассистент кафедры фармации

Russian Federation, Russia, 420012, The Republic of Tatarstan, Kazan, 76 Karl Marx str

Dilyara Shakirova

Kazan (Volga region) Federal University

Email: dhabilevna@mail.ru
ORCID iD: 0000-0002-7840-1985
SPIN-code: 1271-6870

докт. фарм. наук, профессор, заведующий кафедрой фармации

Russian Federation, Russia, 420012, The Republic of Tatarstan, Kazan, 76 Karl Marx str

Yuri Miroshnichenko

Saint Petersburg State Chemical and Pharmaceutical University

Email: miryv61@gmail.com
ORCID iD: 0000-0002-3645-2071
SPIN-code: 9723-1148

доктор фармацевтических наук, профессор, директор института международных образовательных программ ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет» МЗ РФ

Russian Federation, Russian Federation, 197376, Saint Petersburg, Professor Popov St., 14, lit. A

Alexander Perfil'ev

Военно-медицинская академия имени С.М. Кирова

Email: aborisper@gmail.com
ORCID iD: 0000-0002-9947-1296
SPIN-code: 6843-2803

старший преподаватель кафедры ООМИВ(С)

Russian Federation

Sayar Abdulkhakov

Kazan (Volga region) Federal University

Email: sayarabdul@yandex.ru
ORCID iD: 0000-0001-9542-3580
SPIN-code: 4131-8360

канд. мед. наук, доцент, заведующий кафедрой внутренних болезней

Russian Federation, Russia, 420012, The Republic of Tatarstan, Kazan, 76 Karl Marx str.

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 77760 от 10.02.2020.